Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bhaskar Anand Insider Profile
4 Followers
Bhaskar Anand, SVP & CAO at Reata Pharmaceuticals, holds 131.43K shares in Summit Therapeutics (Ticker: SMMT), holds 0.00 shares in Reata Pharmaceuticals (Ticker: RETA).
Bhaskar Anand Reata Pharmaceuticals (RETA)SVP & CAO
Reata Pharmaceuticals (RETA)
SVP & CAO
Not Ranked
Ranked #97,305 out of 100,202 Corporate Insiders
Bhaskar Anand has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CAO
Roles that Bhaskar Anand holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bhaskar Anand
Bhaskar Anand's Trading History
Reata Pharmaceuticals
Sep 26, 2023
―
Uninformative Sell
―
$0.00
Summit Therapeutics
Sep 13, 2024
CAO
Uninformative Buy
499.99K
$2.50M
List of latest transactions for each holding click on a transaction to see Bhaskar Anand's performance on stock
You May Also Like
Bhaskar Anand insider profile FAQ
What is the percentage of profitable transactions made by Bhaskar Anand?
The percentage of profitable transactions made by Bhaskar Anand is ―.
What is the average return per transaction made by Bhaskar Anand?
The average return per transaction made by Bhaskar Anand is ―.
What stocks does Bhaskar Anand hold?
Bhaskar Anand holds: RETA, SMMT stocks.
What was Bhaskar Anand’s latest transaction?
Bhaskar Anand latest transaction was an Uninformative Buy of $499.99K.
What was Bhaskar Anand's most profitable transaction?
Bhaskar Anand’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bhaskar Anand's role in Reata Pharmaceuticals?
Bhaskar Anand's role in Reata Pharmaceuticals is SVP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.